AreƱo, Edna L.
HRN: 22-48-70 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/20/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
03/20/2023
03/26/2023
IV
600mg
Q8
SSI
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes